drugset / Trial / NCT05723731

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Chronic Constipation

NCT05723731

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The worldwide prevalence of chronic constipation (CC) is 15%, and women are more likely to develop the disease than men. CC have a significant impact on quality of life and increase the burden of national health insurance. The conventional medication treatments are primarily symptom-specific and have limited efficacy. Previous small sample study had shown the therapeutic potential of transcutaneous auricular vagus nerve stimulation (taVNS) for irritable bowel syndrome with constipation (IBS-C). The aim of this study was to investigate whether taVNS could improve defecation condition and constipation symptoms in patients with CC.

Timeline

Start
2023-01-03
Primary completion
2023-07-31
Completion
2023-09-28

Drugs

EvaluationDrugModalityDoseRoute
Background Bisacodyl Small molecule
Background Glycerin Other / unclassified Rectal

Indications